References: 1. Data on fi le, Glaukos Corporation. 2. Williams AM et al. Semin Ophthalmol. 2025;40(3):188-195.
©2026 Glaukos Corporation. All rights reserved.
Glaukos is a registered trademark of Glaukos Corporation. PM-US-4053
Keep patients in sight with Glaukos' Interventional Glaucoma portfolio. Learn more about a
proactive, procedure-fi rst alternative to topical drops that doubles the likelihood that patients maintain
follow-up appointments.
1
Speak with your Glaukos representative to learn more.
22
65%
of patients managed on
topical drops lapsed out
of care at 12 months vs
25% of those managed
procedurally
1
2.6X
greater likelihood of
being lost to follow-up
in patients on topical
drops vs those managed
procedurally
1
62%
of patients that lapsed
from care did not return
for 3 years
1
2.2X
higher risk of blindness
in patients that lapsed
for 3+ years
2
2 OF 3 PATIENTS ON GLAUCOMA
DROPS FADE FROM CARE.
1
~
How many patients are disappearing from your care?
Scan to see the full picture.
